1. BOUCHENY A. La feuille de vigne rouge (Vitis vinifera L. var. tinctoria). Mise au point bibliographique et contribution analytique. Thèse de Pharmacie, Paris, 1989.
2. BRUNETON J. Pharmacognosie. Phytochimie, Plantes médicinales. 3e éd., Lavoisier Tec & Doc, Paris 1999, 365-6.
3. DIAZ LANZA AM et al. Flavonoids of 3 cultivars vine leaves, Vitis vinifera L. var. tinctoria(Alicante, Carignan, Grand noir). Value in chemical control. Ann Pharm Fr. 1989 ; 47 (4) : 229-34.
4. JACOB MP et al. Plasma matrix metalloproteinase-9 as a marker of blood stasis in varicose veins. Circulation. 2002 ; 106 (5) : 535-8.
5. JONADETM et al. Anthocyanosides extraits de Vitis vinifera, de Vaccinium myrtillus et de Pinus maritima. Activités inhibitrices vis à- vis de l’élastase in vitro. Activités angio protectrices comparées in vivo. J Pharm Belg. 1983 ; 38 (1) : 41-6.
6. KIESEWETTER H et al. Efficacy of orally administered extract of red vine leaf AS 195 (folia vitis viniferae) in chronic venous insufficiency (stages I-II). A randomized, double blind, placebo-controlled trial. Arzneimittelforschung 2000 ; 50 (2) : 109-17.
7. LECLERCH,Précis de phytothérapie. Thérapeutique par les plantes françaises. Ed Masson, 132.
8. MAFFEI F et al. Free radicals scavenging action and anti-enzyme activities of procyanidines from Vitis vinifera. A mechanism for their capillary protective action. Arzneimittelforschung 1994 ; 44 (5) : 592-601.
9. SCHAEFER E et al. Oedema protective properties of the red vine leaf extract AS 195 (Folia vitis viniferae) in the treatment of chronic venous insufficiency. A 6- week observational clinical trial. Arzneimittelforschung2003 ; 53 (4) : 243-6.
10. ZAMBONI P et al. Urine hemosiderin: A novel marker to assess the severity of chronic venous disease. Journal of Vascular Surgery 2003 ; 37 (1) : 132-136.